Case Reports

Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case
Viviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Andrea Devecchi, Matteo Dugo, Laura Bergamaschi, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Marialuisa Sensi, Licia Rivoltini, Lorenza Di Guardo, Monica Rodolfo

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e007612; DOI: 10.1136/jitc-2023-007612
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade
Julie Stein Deutsch, Jonathan Lai, Kara M Schenk, Abha Soni, Elizabeth M Will, Logan L Engle, Haiying Xu, Alexandra Ogurtsova, Vrinda Madan, Jennifer K Chong, Daphne Wang, Benjamin F Green, Peter Nguyen, Megan D Schollenberger, Evan J Lipson, Janis M Taube

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007463; DOI: 10.1136/jitc-2023-007463
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer
Julia Karbach, Dragan Kiselicki, Kathrin Brand, Claudia Wahle, Evgueni Sinelnikov, Dirk Gustavus, Hans Hoffmeister, Hans-Bernd Prisack, Akin Atmaca, Elke Jäger

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005847; DOI: 10.1136/jitc-2022-005847
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Christian Koch, Juliane Fleischer, Todor Popov, Karl Frontzek, Bettina Schreiner, Patrick Roth, Markus G. Manz, Simone Unseld, Antonia M. S. Müller, Norman F. Russkamp

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006059; DOI: 10.1136/jitc-2022-006059
Durable response of anaplastic thyroid carcinoma to FS118, a bispecific LAG-3/PD-L1 antibody, after checkpoint inhibitor progression: a case report
Maxwell J Kroloff, Josefin-Beate Holz, Omer Stern, Christopher J Shepherd, Michelle Morrow, Louis Kayitalire, Deborah J Wong

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005225; DOI: 10.1136/jitc-2022-005225
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells
Niklas Kehl, Michael Kilian, Julius Michel, Tim R Wagner, Sebastian Uhrig, Alexander Brobeil, Lilli-Sophie Sester, Sven Blobner, Simon Steiger, Michael Hundemer, Niels Weinhold, Karsten Rippe, Stefan Fröhling, Stefan B Eichmüller, Lukas Bunse, Carsten Müller-Tidow, Hartmut Goldschmidt, Michael Platten, Marc-Steffen Raab, Mirco J Friedrich

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005815; DOI: 10.1136/jitc-2022-005815
First communication on the efficacy of combined ¹⁷⁷Lutetium-PSMA with immunotherapy outside prostate cancer
Antonia Digklia, Sarah Boughdad, Krisztian Homicsko, Clarisse Dromain, Mounir Trimech, Ana Dolcan, Solange Peters, John Prior, Niklaus Schaefer

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005383; DOI: 10.1136/jitc-2022-005383
Tumoral melanosis mimicking residual melanoma in the setting of talimogene laherparepvec treatment
Song Y Park, Austin R Green, Rouba Hadi, Coley Doolittle-Amieva, Jennifer Gardner, Ata S Moshiri

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005257; DOI: 10.1136/jitc-2022-005257
Complete response to immunotherapy in a patient with high-risk stage III colorectal cancer after ctDNA-guided detection of early adjuvant treatment failure
Nicholas Lucchesi, Jenna M Ally, Matthew J Reilley

Journal for ImmunoTherapy of Cancer Sep 2023, 11 (9) e007434; DOI: 10.1136/jitc-2023-007434
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report
Carolin Blumendeller, Julius Boehme, Maximilian Frick, Martin Schulze, Antje Rinckleb, Christina Kyzirakos, Simone Kayser, Maria Kopp, Sabine Kelkenberg, Natalia Pieper, Oliver Bartsch, Dirk Hadaschick, Florian Battke, Arnulf Stenzl, Saskia Biskup

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001406; DOI: 10.1136/jitc-2020-001406

Main menu

Case Reports

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Case Reports

Pages